Skip to main content
. 2018 Apr 26;8:93. doi: 10.1038/s41398-018-0138-2

Table 3.

Representation of the private epimutations (lines) in each converter (columns, n = 14)

Genes CpG IC01.001 IC01.010 IC01.037 IC01.048 IC01.055 IC01.063 IC01.098 IC01.105 IC01.119 IC01.151 IC01.153 IC01.178 IC05.001 IC25.001
Before transition
 ALG11; ATP7B cg18796523 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
 CACNB4 cg04087237 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00
 — ch.16,50203861R 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 −0.01 −0.01
 NT5DC3 cg13303475 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 −0.01 0.00
 UBE2T cg01918706 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.00 0.00 0.00 0.00 −0.01 0.01
 KLHL22 cg01657694 0.00 0.01 0.00 0.00 −0.01 0.00 0.00 0.00 0.00 0.00 0.01 0.00 −0.01 0.00
 SIM2 cg13694867 0.00 −0.01 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.00 0.00 0.00 0.00
 EFEMP1 cg05168033 0.00 0.00 0.00 0.00 0.00 0.00 −0.01 0.00 0.00 0.00 0.00 0.00 −0.01 0.00
 ADCY9 cg26952925 0.00 −0.01 0.01 0.00 0.00 0.00 0.01 0.00 0.00 0.00 −0.01 0.00 0.00 0.01
 GPR27; EIF4E3 cg13562542 0.01 0.00 0.00 0.00 −0.01 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00
 PELI1 cg17364044 −0.01 0.01 −0.01 0.00 0.01 0.00 −0.01 0.00 0.00 0.01 −0.01 0.00 0.00 0.00
 GAS1 cg26447413 0.00 −0.01 −0.01 0.01 0.00 0.00 −0.01 0.00 0.00 0.01 0.00 0.00 0.00 0.00
 TMEM132C cg11265160 0.00 −0.01 −0.01 0.01 −0.01 0.00 0.00 0.02 0.00 0.00 0.00 0.00 0.00 −0.01
 LIME1 cg21849932 0.00 0.00 0.00 0.00 0.00 0.00 0.03 0.00 −0.01 0.01 0.00 0.00 −0.01 0.01
 FAM160B1 cg04364540 −0.01 0.00 0.01 0.00 0.02 0.01 0.00 0.00 0.01 0.00 0.01 −0.01 −0.01 −0.01
 PLCXD3 cg14099514 0.00 0.00 −0.01 0.00 −0.01 0.00 −0.01 −0.02 0.00 0.00 −0.02 0.02 0.00 0.01
 — cg19176559 −0.01 −0.01 0.01 0.00 −0.02 0.01 −0.01 −0.01 0.01 0.01 0.01 −0.01 0.00 0.01
 SPHK1 cg19041132 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00
 — cg12053442 −0.01 0.00 −0.01 0.02 0.01 0.01 −0.03 0.00 −0.01 0.02 −0.01 0.00 0.01 −0.01
 HBM cg01558909 0.00 −0.01 −0.01 0.00 0.01 0.01 −0.01 0.03 0.01 0.02 −0.01 0.01 0.00 −0.01
 PCSK9 cg14993491 −0.02 0.01 0.02 −0.02 0.01 0.02 −0.03 −0.01 0.05 0.03 −0.04 −0.02 0.02 −0.02
 — cg13408519 0.02 0.00 −0.01 0.02 0.00 0.02 0.00 −0.02 −0.01 0.02 0.01 0.00 −0.01 −0.01
 CTSH cg12604181 0.00 0.01 0.00 0.00 0.01 0.00 0.00 0.02 0.00 0.00 0.01 0.00 0.00 −0.01
 RAC1 cg18404925 0.00 0.00 −0.01 −0.01 0.01 0.01 −0.02 0.00 0.01 −0.03 0.01 0.00 −0.01 −0.03
 ASTN2 cg13978347 −0.01 −0.03 0.00 0.06 −0.02 0.02 0.01 0.00 0.03 0.01 0.06 −0.04 0.00 0.00
After transition
 Antipsychotic introduction × × × × × ×
 ALG11; ATP7B cg18796523 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.02 −0.01 0.03 0.01 0.00 0.00 0.00
 CACNB4 cg04087237 0.04 0.02 0.00 −0.01 0.00 0.00 −0.01 0.01 0.00 0.00 0.00 0.00 0.00 −0.01
 — ch.16.50203861R 0.00 −0.01 0.00 −0.01 0.01 0.00 0.00 0.00 0.00 0.06 0.00 0.01 0.00 0.00
 NT5DC3 cg13303475 0.00 0.00 0.00 0.00 0.01 −0.01 −0.01 0.00 0.00 0.00 0.00 0.06 −0.01 0.00
 UBE2T cg01918706 0.00 0.00 0.01 0.00 0.00 0.00 0.06 0.00 0.00 0.00 0.01 0.00 0.00 −0.01
 KLHL22 cg01657694 0.03 0.01 0.00 0.01 0.00 0.00 0.00 0.06 0.00 0.00 0.00 0.01 −0.01 −0.01
 SIM2 cg13694867 0.02 0.00 −0.01 0.01 −0.01 −0.02 0.00 0.00 −0.03 −0.01 0.00 −0.01 0.00 0.05
 EFEMP1 cg05168033 0.04 0.01 0.00 0.00 0.00 −0.01 −0.01 0.01 0.00 0.01 0.00 0.01 0.00 0.06
 ADCY9 cg26952925 0.00 0.00 0.00 0.01 0.00 −0.01 0.00 0.01 0.00 0.01 0.00 −0.01 0.00 0.08
 GPR27; EIF4E3 cg13562542 0.07 0.00 −0.02 0.01 0.00 0.00 −0.01 −0.01 0.01 0.00 0.00 0.01 −0.01 0.01
 PELI1 cg17364044 0.00 −0.02 −0.01 −0.01 −0.02 0.00 0.00 0.10 0.00 0.01 0.01 −0.01 −0.01 0.00
 GAS1 cg26447413 −0.01 0.01 0.00 0.01 −0.02 −0.01 −0.01 −0.02 0.01 0.10 −0.01 0.00 0.02 0.00
 TMEM132C cg11265160 0.01 0.08 0.00 0.01 −0.02 −0.05 −0.04 −0.01 0.00 0.00 −0.06 0.00 0.01 0.00
 LIME1 cg21849932 −0.01 0.01 0.00 0.00 0.00 0.01 0.13 0.00 0.00 0.00 0.00 0.00 −0.01 0.00
 FAM160B1 cg04364540 0.00 −0.01 −0.01 0.00 0.01 0.00 0.00 0.01 −0.01 0.00 0.00 0.15 −0.02 0.00
 PLCXD3 cg14099514 0.02 0.03 −0.01 0.00 −0.02 −0.04 −0.01 0.00 −0.01 0.14 −0.03 0.02 0.00 0.00
 — cg19176559 0.04 −0.03 0.00 0.00 −0.01 −0.02 0.15 0.01 0.00 0.01 −0.02 0.01 0.00 0.02
 SPHK1 cg19041132 0.00 0.00 0.00 0.02 0.12 −0.01 0.00 0.01 0.00 0.00 −0.01 0.13 −0.01 0.00
 — cg12053442 −0.01 −0.01 0.01 −0.01 0.00 0.00 −0.01 −0.15 0.01 0.00 0.02 0.00 0.01 −0.11
 HBM cg01558909 0.20 0.00 −0.01 −0.01 0.01 0.29 0.07 0.00 −0.02 0.03 0.01 0.00 −0.01 0.00
 PCSK9 cg14993491 −0.04 0.25 0.02 −0.05 −0.04 0.36 −0.05 −0.02 −0.01 0.02 −0.01 0.01 0.01 0.02
 — cg13408519 −0.01 0.01 −0.01 0.01 −0.02 −0.01 0.00 0.00 0.00 0.00 0.03 0.01 −0.01 0.46
 CTSH cg12604181 0.00 0.00 0.00 0.54 0.09 0.01 0.01 0.00 −0.01 0.00 0.01 −0.01 −0.02 0.00
 RAC1 cg18404925 −0.03 −0.01 0.00 0.06 0.63 0.03 −0.01 −0.01 0.00 0.03 0.02 0.01 −0.02 −0.02
 ASTN2 cg13978347 0.04 −0.02 0.02 −0.01 0.01 0.01 0.03 0.02 −0.05 −0.04 0.02 −0.71 −0.03 −0.01

The value in each case correspond to the deviation from the individual β-value to the group median: relative hypermethylation is in bold and relative hypomethylation in italics